DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death

S. Bonassi*, M. Ceppi, P. Moller, A. Azqueta, M. Milic, N. Monica, G. Brunborg, R. Godschalk, G. Koppen, S.A.S. Langie, J.P. Teixeira, M. Bruzzone, J. Da Silva, D. Benedetti, D. Cavallo, C.L. Ursini, L. Giovannelli, S. Moretti, P. Riso, C. Del Bo'P. Russo, M. Dobrzynska, I.A. Goroshinskaya, E.I. Surikova, M. Staruchova, M. Barancokova, K. Volkovova, A. Kazimirova, B. Smolkova, B. Laffon, V. Valdiglesias, S. Pastor, R. Marcos, A. Hernandez, G. Gajski, B. Spremo-Potparevic, L. Zivkovic, E. Boutet-Robinet, H. Perdry, P. Lebailly, C.L. Perez, N. Basaran, Z. Nemeth, A. Safar, M. Dusinska, A. Collins, D. Anderson, V. Andrade, C.C. Pereira, hCOMET Project

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Article number16793
Number of pages11
JournalScientific Reports
Volume11
Issue number1
DOIs
Publication statusPublished - 18 Aug 2021

Keywords

  • CHROMOSOMAL-ABERRATIONS
  • HUMAN CANCER
  • LYMPHOCYTES PREDICTS
  • FREQUENCY
  • VALIDATION
  • BIOMARKERS
  • HALLMARKS
  • ADDUCTS
  • REPAIR
  • COHORT

Cite this